Every open market buy and sale of Collegium Pharmaceutical, Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $4.4M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when COLL insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an COLL officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every COLL insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| May 18, 2026 | John Gordon FreundDirector | Sale | 20 | $34.05 | $681 | 83,952 | May 20Form 4 |
| May 15, 2026 | John Gordon FreundDirector | Sale | 4,127 | $34.54 | $143K | 83,972 | May 18Form 4 |
| May 13, 2026 | Nancy LurkerDirector | Sale | 4,500 | $35.97 | $162K | 18,017 | May 15Form 4 |
| May 11, 2026 | Garen G BohlinDirector | Sale | 8,700 | $37.18 | $323K | 62,259 | May 13Form 4 |
| Mar 18, 2026 | David DieterEVP & General Counsel | Sale plan | 13,976 | $34.92 | $488K | 77,071 | Mar 20Form 4 |
| Mar 9, 2026 | David DieterEVP & General Counsel | Sale plan | 6,224 | $36.65 | $228K | 91,047 | Mar 11Form 4 |
| Mar 3, 2026 | Scott DreyerEVP & Chief Commercial Officer | Sale plan | 49,976 | $40.40 | $2M | 71,770 | Mar 5Form 4 |
| Dec 8, 2025 | Scott DreyerEVP & Chief Commercial Officer | Sale plan | 17,600 | $48.17 | $848K | 103,613 | Dec 10Form 4 |
| Dec 5, 2025 | Rita J. Balice-GordonDirector | Sale | 3,650 | $47.03 | $172K | 52,629 | Dec 9Form 4 |
| Nov 12, 2025 | John A. FallonDirector | Sale | 34,853 | $47.21 | $1.6M | 64,634 | Nov 14Form 4 |
| Nov 6, 2025 | Colleen TupperEVP & CFO | Sale plan | 30,000 | $40.53 | $1.2M | 126,667 | Nov 7Form 4 |
| Aug 29, 2025 | Thomas B SmithEVP and Chief Medical Officer | Sale | 17,478 | $38.42 | $672K | 70,264 | Sep 3Form 4 |
| Aug 18, 2025 | Scott DreyerEVP & Chief Commercial Officer | Sale plan | 16,389 | $38.21 | $626K | 103,613 | Aug 20Form 4 |
| Aug 15, 2025 | Gino SantiniDirector | Sale | 5,405 | $37.19 | $201K | 95,042 | Aug 19Form 4 |
| Aug 13, 2025 | Rubric Capital Management LP10% owner | Sale | 25,000 | $37.85 | $946K | 3,132,743 | Aug 15Form 4 |
COLL insider trading FAQ
Are COLL insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of COLL on the open market in 0 trades, and 6 sold $4.4M in 9 trades, 82% of that under pre-arranged trading plans.
When did an COLL insider last buy shares?
There has been no open market insider purchase of COLL in the last two years.
When did an COLL insider last sell shares?
John Gordon Freund (Director) sold 20 shares for $681 on May 18, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
